David Benjamin Konrad

A Nontoxin Aminopyrimidine Probe for Near State-Independent NaV1.7 Inhibition

Abstract The voltage-gated sodium channel NaV1.7 is among the most compelling genetically validated pain targets; however, advanced small-molecule inhibitors, including voltage-sensing domain IV (VSD4)-directed series, have not yet achieved robust clinical efficacy, potentially r...